Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis by Fokkens, Wytske J., Mullol, Joaquim, Kennedy, David, Philpott, Carl, Seccia, Veronica, Kern, Robert C., Coste, André, Sousa, Ana R., Howarth, Peter H., Benson, Victoria S., Mayer, Bhabita, Yancey, Steve W., Chan, Robert, Gane, Simon B.

Get full text

Mepolizumab improves clinical outcomes in patients with severe asthma and comorbid conditions by Gibson, Peter G, Prazma, Charlene M, Chupp, Geoffrey L, Bradford, Eric S, Forshag, Mark, Mallett, Stephen A, Yancey, Steve W, Smith, Steven G, Bel, Elisabeth H

Get full text

Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count by Bachert, Claus, Sousa, Ana R., Han, Joseph K., Schlosser, Rodney J., Sowerby, Leigh J., Hopkins, Claire, Maspero, Jorge F., Smith, Steven G., Kante, Oliver, Karidi-Andrioti, Despina E., Mayer, Bhabita, Chan, Robert H., Yancey, Steve W., Chaker, Adam M.

Get full text

Controller medications and their effects on asthma exacerbations temporally associated with upper respiratory infections by Prazma, Charlene M, Kral, Kenneth M, Gul, Nadeem, Yancey, Steve W, Stempel, David A

Get full text

One-year claims analysis comparing inhaled fluticasone propionate with zafirlukast for the treatment of asthma by Stempel, David A., Meyer, Jay W., Stanford, Richard H., Yancey, Steve W.

Get full text